63 Cervical cancer treated with a combination of External Beam Radiation (EBRT) and HDR brachytherapy: a retrospective analysisDendritic cellsDC1 polarizationEffector CD8(+) T cellsIL-12p70CancerAlthough the proapoptotic BH3-only protein, Bim, is required for deletion of autoreactive thymocytes, Bim...
Two-dimensional high-dose-rate brachytherapy (2D-HDR-BT) is an effective method of dose escalation for local tumor control in early T-stage nasopharyngeal carcinoma (NPC). Treatment outcomes for 3D-image-guided high-dose-rate brachytherapy (3D-image-guided-HDR-BT) after external beam radiotherapy...
Boost can be applied by EBRT sequentially or simultaneously or by interstitial brachytherapy (ISBT). In contrast to an EBRT boost, adaptive brachytherapy (BT), as a highly conformal RT method, allows targeted radiation of the residual tumor, thus reducing toxicity to the organs at risk (OAR) ...
To evaluate the relationship between delivered radiation (RT) and post-RT inversion-recovery ultrashort-echo-time (IR-UTE) MRI signal-intensity (SI) in gynecologic cancer patients treated with high-dose-rate (HDR) brachytherapy (BT). Seven patients under
Purpose/Objective(s) The role of supplemental External Beam Radiation Therapy (EBRT) in brachytherapy is controversial. We compare our results of HDR + IMRT vs. HDR monotherapy. Materials/Methods Between 1997 and 2010, 421 patients with T1 and T2 localized prostate underwent TRUS guided interstitial...
Methods A cohort of 32 patients receiving post‐EBRT HDR brachytherapy boost with a prescription dose of 5.5Gy × 5 fractions to the high‐risk clinical target volume (CTVHR) were selected for this study. For standard TG43 dose calculation, applicators were manually digitized on the planning ...
PO-1048: HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trialPurpose To determine the demographic, clinical, decision-making, and quality-of-life factors that are associated ... A Tétreault-Laflamme,TV Nguyen,F Vincent,... - 《Ra...
The mean TRD was 32.2 and 25.8 months with a mean nPSA of 45.9 and 38.4 months for EBRT and PPI patients, respectively. Over time, our results suggest a gradual increase in atrophy and a consistent decline in cancerous metabolism. The data suggests that CMA is expected for brachytherapy ...
Background Two-dimensional high-dose-rate brachytherapy (2D-HDR-BT) is an effective method of dose escalation for local tumor control in early T-stage nasopharyngeal carcinoma (NPC). Treatment outcomes for 3D-image-guided high-dose-rate brachythera
High-dose-rate (HDR) brachytherapy is a logical treatment modality to deliver the boost dose to an external beam radiation therapy (EBRT) treatment to increase local control rates. From a treatment perspective, the utilization of a complicated treatment delivery system, the compressed time frame in...